Advancing Clinical Research Through Blood Test-Based Trials in Mesothelioma Studies
Blood test-based clinical trials are transforming mesothelioma research by facilitating early diagnosis, monitoring disease progression, and tailoring treatments more precisely. These non-invasive methods offer promising avenues to improve patient outcomes and accelerate therapeutic development. As research advances, understanding the role of blood tests in mesothelioma clinical trials becomes essential for patients, clinicians, and advocates alike. … Read more